- Home
- TALO vs OCUL Comparison
TALO vs OCUL Comparison
Compare TALO & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TALO | OCUL |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TALO | OCUL |
|---|---|---|
| Price | $16.17 | $9.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $18.00 | ★ $23.56 |
| AVG Volume (30 Days) | 1.7M | ★ 2.9M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,780,070,000.00 | $1,990,000.00 |
| Revenue This Year | $4.18 | $7.93 |
| Revenue Next Year | N/A | $96.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $7.27 | $6.23 |
| 52 Week High | $17.01 | $16.44 |
Technical Indicators
Market Signals| Indicator | TALO | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 60.13 | 58.09 |
| Support Level | $10.49 | $8.36 |
| Resistance Level | $17.01 | $9.91 |
| Average True Range (ATR) | 0.60 | 0.41 |
| MACD | 0.11 | 0.03 |
| Stochastic Oscillator | 100.00 | 78.85 |
Price Performance
Historical ComparisonAbout TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. Its revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.